Morgan Stanley & Co. LLC and Leerink Partners LLC led the underwriting efforts for Abivax, with the potential to raise an additional $271 million if they choose to exercise an overallotment option over the next 30 days.
Legal Teams in Action
Cooley’s legal team, led by partners Div Gupta, Marc Recht, Ryan Sansom, and Denny Won, along with associate Minkyu Park, exhibited their legal prowess. On the other hand, Dechert’s legal team, under the guidance of partners Alain Decombe and Vianney Toulouse, played an instrumental role in this feat.
The underwriters also had their legal guardians in the form of Latham & Watkins LLP, led by partners Nathan Ajiashvili and Alison Haggerty, and Gide Loyrette Nouel LLP, guided by partners Arnaud Duhamel and Guilhem Richard.
Abivax’s $236M US IPO has made a resounding entry into the financial world, offering a tantalizing glimpse of the company’s innovative future in the biotechnology sector.
